FDA approves Jazz Pharmaceuticals’ Xywav for idiopathic hypersomnia

, , , , , , , , ,

The U.S. Food and Drug Administration approved Jazz Pharmaceuticals’ Xywav for idiopathic hypersomnia in adults.

Read more
/by